20.2.2017
•
News
KŠB once again nominated as Law Firm of the Year in Chambers Europe Awards 2017
KŠB has been once again nominated for a Chambers Europe Award in the category of best law firm in the Czech Republic. This prestigious award is announced annually by the renowned British ratings agency Chambers and Partners.
KŠB is no newcomer in this category, having already won the award three times, first in 2008 (as the very first Czech law firm to achieve the honour) and then also in 2013 and 2015. In addition to the years in which it won, KŠB has also regularly been shortlisted for the award. This year, KŠB is one of six firms nominated, three of which are are local Czech firms.
This year’s winner for the Czech Republic will be announced on Friday, 7 April 2017 at the awards ceremony in London.
Other articles
8.7.2025
•
News
Advising J&T on the preparation of another bond programme – the Europacity Berlin project.
KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. Het basenprospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. Vlastimil Pihera.
7.7.2025
•
News
A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein
Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
•
News
KŠB advised the seller on the sale of mcePharma to the Brenntag Group
The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.
